Literature DB >> 8691025

Inactivation of V79 cells by low-energy protons, deuterons and helium-3 ions.

M Folkard1, K M Prise, B Vojnovic, H C Newman, M J Roper, B D Michael.   

Abstract

Previous work by ourselves and by others has demonstrated that protons with a linear energy transfer (LET) about 30 keVmum(-1)are more effective at killing cells than doubly charged particles of the same LET. In this work we show that by using deuterons, which have about twice the range of protons with the same LET, it is possible to extend measurements of the RBE of singly charged particles to higher LET (up to 50 keVmum(-1). We report the design and use of a new arrangement for irradiating V79 mammalian cells. Cell survival measurements have been made using protons in the energy range 1.0-3.7 MeV, deuterons in the energy range 0.9-3.4MeV and 3He2+ ions in the energy range 3.4-6.9 MeV. This corresponds to volume-averaged LET (within the cell nucleus) between 10 and 28 keVmum(-1) for protons, 18-50 keVmum(-1) for deuterons, and 59-106 keVmum(-1) for helium ions. Our results show no difference in the effectiveness of protons and deuterons matched for LET. However, for LET above about 30 keVmum(-1) singly charged particles are more effective at inactivating cells than doubly-charged particles of the same LET and that this difference can be understood in terms of the radial dose distribution around the primary ion track.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8691025     DOI: 10.1080/095530096145472

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  15 in total

1.  Radiation-induced synthetic lethality: combination of poly(ADP-ribose) polymerase and RAD51 inhibitors to sensitize cells to proton irradiation.

Authors:  Anne-Catherine Wéra; Alison Lobbens; Miroslav Stoyanov; Stéphane Lucas; Carine Michiels
Journal:  Cell Cycle       Date:  2019-06-25       Impact factor: 4.534

2.  "Broadbeam" irradiation of mammalian cells using a vertical microbeam facility.

Authors:  J C G Jeynes; M J Merchant; L Barazzuol; M Barry; D Guest; V V Palitsin; G W Grime; I D C Tullis; P R Barber; B Vojnovic; K J Kirkby
Journal:  Radiat Environ Biophys       Date:  2013-08-21       Impact factor: 1.925

3.  Phenomenological explanation of cell inactivation cross section in terms of direct and indirect action.

Authors:  Faika A Azooz; Suaad A Meerkhan
Journal:  Sultan Qaboos Univ Med J       Date:  2010-04-17

4.  Modeling radiation-induced cell death: role of different levels of DNA damage clustering.

Authors:  M P Carante; S Altieri; S Bortolussi; I Postuma; N Protti; F Ballarini
Journal:  Radiat Environ Biophys       Date:  2015-05-09       Impact factor: 1.925

5.  A phenomenological relative biological effectiveness (RBE) model for proton therapy based on all published in vitro cell survival data.

Authors:  Aimee L McNamara; Jan Schuemann; Harald Paganetti
Journal:  Phys Med Biol       Date:  2015-10-13       Impact factor: 3.609

6.  Proton Relative Biological Effectiveness - Uncertainties and Opportunities.

Authors:  Harald Paganetti
Journal:  Int J Part Ther       Date:  2018-09-21

7.  Study of the Influence of NanOx Parameters.

Authors:  Caterina Monini; Micaela Cunha; Etienne Testa; Michaёl Beuve
Journal:  Cancers (Basel)       Date:  2018-03-21       Impact factor: 6.639

8.  Microdosimetric calculation of relative biological effectiveness for design of therapeutic proton beams.

Authors:  Yuki Kase; Wataru Yamashita; Naruhiro Matsufuji; Kenta Takada; Takeji Sakae; Yoshiya Furusawa; Haruo Yamashita; Shigeyuki Murayama
Journal:  J Radiat Res       Date:  2012-11-23       Impact factor: 2.724

9.  Systematic analysis of RBE and related quantities using a database of cell survival experiments with ion beam irradiation.

Authors:  Thomas Friedrich; Uwe Scholz; Thilo Elsässer; Marco Durante; Michael Scholz
Journal:  J Radiat Res       Date:  2012-12-23       Impact factor: 2.724

10.  Calculating Variations in Biological Effectiveness for a 62 MeV Proton Beam.

Authors:  Mario Pietro Carante; Francesca Ballarini
Journal:  Front Oncol       Date:  2016-04-06       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.